Ophthalmic Formulation Development: Inside Ophthalmic Preparation

Ophthalmic formulation development is receiving more attention in the pharmaceutical industry as of late thanks to advances in technology, increasing awareness of eye diseases, and an aging population. As people live longer, the need to find innovations in treating cataracts, macular degeneration, glaucoma, and diabetic retinopathy grows. 

As pharmaceutical companies anticipate continued growth in this market, the demand for contract development and manufacturing organizations (CDMOs) with experience in the formulation of ophthalmic products is on the rise.